David Gerber, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Karyopharm
    Topic: 
    Clinical trial
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    BerGenBio
    Topic: 
    Clinical trial
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    AstraZeneca
    Topic: 
    Clinical trial
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Sagimet
    Topic: 
    Clinical trial
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    Gilead
    Topic: 
    Medicine
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Catalyst Therapeutics
    Topic: 
    Consulting
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Janssen
    Topic: 
    Advisory Board
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Sanofi
    Topic: 
    Advisory Board
    Date added: 
    01/03/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Regeneron
    Topic: 
    Advisory Board
    Date added: 
    01/03/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    Walgreens
    Topic: 
    Pharmacy
    Date added: 
    05/16/2023

Pages

Return to ASCO Reflections and Highlights Conference 2024 (RP2407A)